| Randomized assessment of rapid endovascular treatment of ischemic stroke. ET Investigators. New England Journal of Medicine 372 (11), 1019-1030, 2015 | 6642 | 2015 |
| Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation ECB Johnson, EB Dammer, DM Duong, L Ping, M Zhou, L Yin, ... Nature medicine 26 (5), 769-780, 2020 | 633 | 2020 |
| Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial MD Hill, M Goyal, BK Menon, RG Nogueira, RA McTaggart, AM Demchuk, ... The Lancet 395 (10227), 878-887, 2020 | 462 | 2020 |
| HERMES collaborators. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus … BCV Campbell, WH van Zwam, M Goyal, BK Menon, DWJ Dippel, ... Lancet Neurol 17 (01), 47-53, 2018 | 371* | 2018 |
| Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data L San Román, BK Menon, J Blasco, M Hernández-Pérez, A Dávalos, ... The Lancet Neurology 17 (10), 895-904, 2018 | 350 | 2018 |
| Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease S Rangaraju, EB Dammer, SA Raza, P Rathakrishnan, H Xiao, T Gao, ... Molecular neurodegeneration 13, 1-25, 2018 | 305 | 2018 |
| Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1. 3 channel block MP Matheu, C Beeton, A Garcia, V Chi, S Rangaraju, O Safrina, ... Immunity 29 (4), 602-614, 2008 | 242 | 2008 |
| Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta … BCV Campbell, WH Van Zwam, M Goyal, BK Menon, DWJ Dippel, ... The Lancet Neurology 17 (1), 47-53, 2018 | 235 | 2018 |
| Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry JE Siegler, P Cardona, JF Arenillas, B Talavera, AN Guillen, ... International Journal of Stroke 16 (4), 437-447, 2021 | 160 | 2021 |
| C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19 M Sharifpour, S Rangaraju, M Liu, D Alabyad, FB Nahab, CM Creel-Bulos, ... PloS one 15 (11), e0242400, 2020 | 160 | 2020 |
| Engineering a stable and selective peptide blocker of the Kv1. 3 channel in T lymphocytes MW Pennington, C Beeton, CA Galea, BJ Smith, V Chi, KP Monaghan, ... Molecular pharmacology 75 (4), 762-773, 2009 | 159 | 2009 |
| Predictors of good outcome after endovascular therapy for vertebrobasilar occlusion stroke M Bouslama, DC Haussen, A Aghaebrahim, JA Grossberg, G Walker, ... Stroke 48 (12), 3252-3257, 2017 | 125 | 2017 |
| Potassium channel Kv1. 3 is highly expressed by microglia in human Alzheimer's disease S Rangaraju, M Gearing, LW Jin, A Levey Journal of Alzheimer's disease 44 (3), 797-808, 2015 | 118 | 2015 |
| Kv1. 3 potassium channels as a therapeutic target in multiple sclerosis S Rangaraju, V Chi, MW Pennington, KG Chandy Expert opinion on therapeutic targets 13 (8), 909-924, 2009 | 107 | 2009 |
| Differential phagocytic properties of CD45low microglia and CD45high brain mononuclear phagocytes—activation and age-related effects S Rangaraju, SA Raza, NXA Li, R Betarbet, EB Dammer, D Duong, JJ Lah, ... Frontiers in immunology 9, 343419, 2018 | 103 | 2018 |
| Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer’s disease-related proteins S Rangaraju, EB Dammer, SA Raza, T Gao, H Xiao, R Betarbet, ... Molecular neurodegeneration 13, 1-19, 2018 | 99 | 2018 |
| Potassium channel modulation by a toxin domain in matrix metalloprotease 23 S Rangaraju, K Khoo, Z Feng, G Crossley, D Nugent, I Khaytin, ... Biophysical Journal 98 (3), 212a, 2010 | 95 | 2010 |
| Automated ct perfusion ischemic core volume and noncontrast ct aspects (alberta stroke program early ct score) correlation and clinical outcome prediction in large vessel stroke DC Haussen, S Dehkharghani, S Rangaraju, LC Rebello, M Bouslama, ... Stroke 47 (9), 2318-2322, 2016 | 93 | 2016 |
| Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer’s disease: preclinical proof of concept I Maezawa, HM Nguyen, J Di Lucente, DP Jenkins, V Singh, S Hilt, K Kim, ... Brain 141 (2), 596-612, 2018 | 91 | 2018 |
| Comparison of 3-month stroke disability and quality of life across modified Rankin scale categories S Rangaraju, D Haussen, RG Nogueira, F Nahab, M Frankel Interventional neurology 6 (1-2), 36-41, 2017 | 91 | 2017 |
Allan I Levey, MD, PhDEmory University School of MedicineVerified email at emory.edu
